Filing Details

Accession Number:
0001104659-23-083472
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-24 16:45:52
Reporting Period:
2023-07-20
Accepted Time:
2023-07-24 16:45:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1875558 Nuvectis Pharma Inc. NVCT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251213 Ron Bentsur C/O Nuvectis Pharma, Inc.
1 Bridge Plaza, Suite 275
Fort Lee NJ 07024
Chairman & Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-07-20 110 $15.06 3,231,669 No 4 P Direct
Common Stock Acquisiton 2023-07-21 225 $14.85 3,231,894 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 426,759 shares of restricted stock.
  2. Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.55 to $15.14. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.